NCT03520842 2023-08-01
Regorafenib and Methotrexate in Treating Participants With Recurrent or Metastatic KRAS Mutated Non-Small Cell Lung Cancer
Stanford University
Phase 2 Completed
Clinical Trials
3 trialsNCT00992602 2017-07-07
Liposomal Cytarabine and High-Dose Methotrexate in Treating Patients With Central Nervous System Metastases From Breast Cancer
University of Washington
Phase 2 Completed
NCT01438021 2012-11-09
Continuous Intraventricular Methotrexate in Treating Patients With Leptomeningeal Disease
City of Hope Medical Center
Phase NA Withdrawn